BIO-MATRIX SCIENTIFIC GROUP
The focus of Regen BioPharma, Inc. is to developing translational medicine platforms for the rapid commercialization of stem cell therapies and to advance intellectual property licensed from entities, institutions and universities that show promise towards fulfilling the purpose of increased quality of life. Regen BioPharma has reviewed more than 20,000 US issued patents covering stem cell related subject matter, created a shortlist of 30 promising technologies for rapid commercialization, and c... urrently is in negotiations to license several of these. The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human "safety and signal of efficacy" stage (Phase I/II clinical trials), followed by exit. Having assembled a core infrastructure specialized in obtaining regulatory approval and executing clinical trials in cell therapy, we aim to act as a "superincubator" that within 1-2 years grows technologies from laboratory to an asset ready for spin-off or sale.
BIO-MATRIX SCIENTIFIC GROUP
Social Links:
Industry:
Biotechnology Enterprise Applications Medical
Founded:
2005-01-01
Address:
La Mesa, California, United States
Country:
United States
Website Url:
http://www.regenbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(619) 702-1404
Total Funding:
50 K USD
Technology used in webpage:
SPF Register.com DNS Network Solutions
Similar Organizations
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tarsa Therapeutics
Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.regenbiopharma.com
- Host name: wf.networksolutions.com
- IP address: 205.178.189.131
- Location: Jacksonville United States
- Latitude: 30.1426
- Longitude: -81.5727
- Metro Code: 561
- Timezone: America/New_York
- Postal: 32258
More informations about "Bio-Matrix Scientific Group"
About Us | Regen BioPharma, Inc.
Learn about our target disease indications, management team, scientific advisory board and our intellectual property.See details»
Checkpoint Inhibitors and Cancer Vaccines | Regen …
Regen BioPharma, Inc. is developing CAR-T cells and cancer vaccines using DNA and RNA technologies to target immune checkpoints.See details»
Regen BioPharma (RGBP) Company Profile & Description
Mar 17, 2025 Company profile for Regen BioPharma, Inc. (RGBP) with a description, list of executives, contact details and other key facts.See details»
Regen BioPharma Company Profile | Management and Employees …
Find contact information for Regen BioPharma. Learn about their Research & Development, Business Services market share, competitors, and Regen BioPharma's email format.See details»
Regen BioPharma - Crunchbase Company Profile
Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP) focused on the immunology and immunotherapy space. The Company plans to rapidly advance novel technologies through pre …See details»
Regen Biopharma Inc. Company Profile | La Mesa, CA
Find company research, competitor information, contact details & financial data for Regen Biopharma Inc. of La Mesa, CA. Get the latest business insights from Dun & Bradstreet.See details»
Regen BioPharma, Inc. (RGBPP) - Yahoo Finance Canada
See the company profile for Regen BioPharma, Inc. (RGBPP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Regen BioPharma Inc : Shareholders Board Members Managers …
Business Summary Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel …See details»
Investor Relations | Regen BioPharma, Inc.
Regen BioPharma, Inc. is a publicly traded biotechnology company focused on the immunology and immunotherapy space.See details»
Regen BioPharma Inc. | Key People and Executives - statinvestor.com
Jul 8, 2019 Regen BioPharma Inc. board of directors, ownership, key people and executives. Detailed company description, list of companies executives for Regen BioPharma Inc.See details»
Regen BioPharma - Craft
Oct 29, 2024 Regen BioPharma is a biotech company focused on the immunology and immunotherapy space. It is engaged in the development of small molecule therapies for …See details»
Governance Regen BioPharma, Inc. - MarketScreener.com
Dec 22, 2007 Find the composition of the Board of Directors of Regen BioPharma, Inc. (OTC Markets Stock Exchange), the gender parity as well as the age distribution of the insiders.See details»
RGBP - Regen Biopharma, Inc. | Company Profile | OTC Markets
2 days ago Regen BioPharma Inc. is a publicly traded biotechnology company (OTCQB: RGBP) and (OTCQB: RGBPP). The Company is focused on the immunology and immunotherapy …See details»
Regen BioPharma, Inc. issues Message to the Shareholders from …
Dec 19, 2022 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) As 2022 comes to a close, I would like to highlight some our many accomplishments...See details»
Regen BioPharma - Products, Competitors, Financials, Employees ...
About Regen BioPharma Regen BioPharma is a biotechnology company focused on developing innovative treatments in the fields of immune-oncology and autoimmune diseases. The …See details»
Regen BioPharma - PitchBook
Information on stock, financials, earnings, subsidiaries, investors, and executives for Regen BioPharma. Use the PitchBook Platform to explore the full profile.See details»
RYGEN BIOPHARMA
RyGen Biopharma, a dynamic biotechnology start-up based in Hyderabad, India, is dedicated to advancing the boundaries of biotechnology. Led by industry veterans, our team of experts in r …See details»
Company Regen BioPharma, Inc. Other OTC - MarketScreener.com
Apr 23, 2012 Regen BioPharma Inc. is a biotechnology company. The Company is focused on the immunology and immunotherapy space. The Company is developing treatments using …See details»
Regen BioPharma, Inc.: Shareholders, Shareholding Structure ...
Mar 13, 2025 Find the distribution by types of shareholders of Regen BioPharma, Inc. listed on the OTC Markets stock exchange. Discover the geographical origin of the shareholders of …See details»
Regen BioPharma, Inc. Is Raising Capital for Their FDA Phase I …
Dec 9, 2024 (OTC:PINK #RGBP #RGBPP) Regen stated on The Emerging Growth Conference (ECG) 77 - Day 1 December 4, 2024 they're Raising Capital to Commence and Complete FDA …See details»